ROLE OF FENOFIBRATE IN MANAGEMENT OF UNCONJUGATED HYPERBILIRUBINEMIA IN NEONATES.
• 2016
معلومات البحث
المؤلفون
Shahien A Dabour1, Yasser M Ismael2, Effat H Assar3 and Mostafa M Allam4.
الكلمات المفتاحية
Not Available
المجلة العلمية
Not Available
الناشر
Not Available
المجلد
Not Available
العدد
Not Available
الصفحات
Not Available
publication.type
International
رابط البحث
Not Available
المواد المرفقة
Not Available
الملخص
Background: Jaundice is an important problem in the first week of life. It is a cause of concern for the physician and a source of anxiety for the parents. Fibrates can increase bilirubin conjugation and excretion via induction of glucuronyltransferase activity. Methods: Forty full term neonates admitted to the "N.I.C.U." of Benha Children Hospital suffering from neonatal indirect hyperbilirubinemia. Twenty neonates received fenofibrate (10 mg/kg) as adjuvant therapy in addition to phototherapy while the other twenty neonates received phototherapy alone. Results: we found that neonates treated with fenofibrate and phototherapy had 5.3 mean NICU stay which is shorter than NICU stay of neonates treated with phototherapy alone whose admission duration mean was 5.8 . Conclusion:Our study revealed that use of fenofibrate in addition to phototherapy has additional benefit regarding time of stay and rate of bilirubin reduction in comparison to treatment with phototherapy alone.
أعضاء هيئة التدريس - جامعة بنها